XORTX Therapeutics Inc. (XRTX) NASDAQ
2.20
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.20
+0(+0.00%)
Currency In USD
| Market Cap | 532,171.85 |
| Enterprise Value | -293,549 |
| P/E Ratio | -1.15 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.47 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.28 |
| Return On Equity | -1.35 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -3.14M |
| Net Income | -2.66M |
| Diluted EPS | -14.2 |
| Total Cash | 251,098 |
| Total Cash/Share | 0.18 |
| Total Debt | 15,105 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 0.43 |
| Book Value Per Share | 0.92 |
| 52-Week Change | -53.19 |
| 52-Week High | 7.05 |
| 52-Week Low | 1.73 |
| Moving Average 50 Days | 2.4 |
| Moving Average 200 Days | 2.98 |
| Average Volume | 1.23M |
| Shares Outstanding | 278,489 |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | April 06, 2026 |